Cargando…
Innovations in oligonucleotide drug delivery
Oligonucleotides (ONs) are a new class of therapeutic compounds under investigation for the treatment of a variety of disease states, such as cancer and HIV, and for FDA approval of an anti‐CMV retinitis antisense molecule (Vitravene™, Isis Pharmaceuticals). However, these molecules are limited not...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094321/ https://www.ncbi.nlm.nih.gov/pubmed/12884243 http://dx.doi.org/10.1002/jps.10399 |